Our Blog | Biosimilars & Generics | AAM

New White Paper - Read AAM Report on Drug Shortages

Biocon Biologics

Sep 13, 2023 | Jewel Smith

Member Spotlight: Biocon Biologics

Semglee Launch Tracking 2023

Jul 17, 2023 | Craig Burton

Pharmacy Benefit Managers Are Blocking Patient Access to Biosimilar Insulin

AAM - Your Generics & Biosimilars Industry

Jun 28, 2023 | Monét Stanford

U.S. Patients Rely On Generic Medicines But Increases In Drug Shortages Reflect Challenges To Their Long-Term Sustainability

May 12, 2023 | Jewel Smith

Associate Members Spotlight: Antheia

Moms should never be taken #4GRxANTED

May 10, 2023 | Erica Klinger

Shamekka Shares Why We Should Never Take Moms #4GRxANTED

Feb 24, 2023 | Erica Klinger

A Look Back at Access! 2023

Feb 9, 2023 | Jonathan Kimball

The Quickest Route to U.S. Essential Medicines Production: Existing and Idle Production Sites

Desi, MD | Autoimmune disease

Jan 5, 2023 | Erica Klinger

Desi is Back Playing Soccer and Doing "Normal Kid" Stuff

Group of Patients

Jan 3, 2023 | Sara Skubikowski

Generics and Biosimilars Offer Savings for Patients Fighting Cancer, Heart Disease and Other Conditions

AAM - Your Generics & Biosimilars Industry

Dec 21, 2022 | Craig Burton

Ensuring Patient Access to Amoxicillin When Demand is High

GRx+Biosims 2022 attendees

Nov 23, 2022 | Erica Klinger

Back Together: GRx+Biosims 2022 Conference Recap

Medicare

Oct 19, 2022 | Monét Stanford

Patients Pay More When Generic Drugs Are Placed On Non-Generic Tiers, Even Though Prices For Generics Are Going Down